Deep 6 AI announced the addition of Trial Recommender to its artificial intelligence (AI)-driven clinical trial acceleration platform. Trial Recommender lets physicians and their patients easily discover and participate in clinical research.
Leveraging the Deep 6 AI and NLP platform, Trial Recommender offers precision-matched clinical trial opportunities for patients, during their visit with a treating physician, based on real-time structured and unstructured clinical data.
Starting inside their EMR or the Trial Recommender portal, a physician can review precision-matched trial opportunities for their patients to determine study fit and impact. This empowers doctors to give their patients access to treatments and make data-driven decisions about their care. Trial Recommender also operates across the Deep 6 site network.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.